Vaccines play a pivotal role in safeguarding public health by preventing the spread of infectious diseases. The vaccines played a super important role in the COVID-19 pandemic and single-handedly stopped the same. But how do we ensure they are safe and effective before they reach us?
The journey of a vaccine from concept to approval is a tedious scientific process, primarily involving clinical trials. Let’s understand this journey in simple terms and how vaccines are rigorously tested and approved to ensure they’re safe and beneficial.
Stages of Clinical Trials for Vaccines
#1 – Preclinical Testing
The journey of a vaccine starts in laboratories, where scientists brainstorm and design the chemical structure of the potential vaccines. They identify the virus or bacteria that causes the disease and learn how to train the body’s immune system to recognize and fight it. In the preclinical phase, these potential vaccines are tested on cells and animals to ensure they trigger the desired immune response and show no harmful effects.
#2 – Clinical Trials – Phase 1
Once the potential vaccine shows promise in the lab, it’s time for the first human trials. This is called the Phase one of clinical trials. A small group of healthy volunteers is given the vaccine to test its safety and dosage. Researchers carefully monitor them to see how the human body reacts and if there are any side effects. The focus is on safety at this stage. The research is moved to the second phase if the vaccine shows promising results.
#3 – Clinical Trials – Phase 2
If the Phase One trials are successful and the vaccine proves safe, it progresses to Phase Two. In this stage, a larger group of people, often hundreds, receive the vaccine. Researchers look at how the vaccine behaves in different populations, including various age groups and those with underlying health conditions. They also continue to monitor safety and begin assessing its effectiveness.
#4 – Clinical Trials – Phase 3
Phase Three is the final phase of clinical trials before getting the authority’s approval. Thousands of volunteers receive the vaccine to evaluate its safety and effectiveness further. Some receive the vaccine, while others receive a placebo. Researchers compare the outcomes between the two groups to ensure the vaccine is protective and safe for a broader population. All the data is collected in this phase to share with the authorities.
#5 – Regulatory Approval
After successful Phase Three trials, independent regulatory authorities, like the Food and Drug Administration (FDA), carefully review the vaccine’s data. They scrutinize the results, safety data, and effectiveness before deciding whether to approve the vaccine. Once approved, the vaccine can be distributed for public use.
This rigorous journey of testing and approval assures us that vaccines reaching the public are thoroughly checked for safety, effectiveness, and suitability for a diverse population. Every vaccine has undergone the same process, so we are healthy individuals who eradicate deadly diseases.
- Artificial Intelligence in Clinical Trials: How to Navigate the Promise and Perils
- Decentralized Clinical Trials: How the FDA is Supporting its Growth
- Patient Engagement Scores: How Do Different Therapeutic Areas Compare?